Conmed (CNMD) Profit After Tax Growth (3y) (2013 - 2026)
Conmed (CNMD) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.68% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.83% |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn | 48.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.70% |
| Dec 31, 2025 | -11.99% |
| Sep 30, 2025 | -59.53% |
| Jun 30, 2025 | 29.06% |
| Mar 31, 2025 | -22.98% |
| Dec 31, 2024 | 13.42% |
| Sep 30, 2024 | 48.25% |
| Jun 30, 2024 | 12.62% |
| Mar 31, 2024 | 23.18% |
| Dec 31, 2023 | 6.51% |
| Sep 30, 2023 | 32.23% |
| Jun 30, 2023 | 38.17% |
| Mar 31, 2023 | 83.59% |
| Dec 31, 2022 | 24.56% |
| Sep 30, 2022 | 83.58% |
| Jun 30, 2022 | -218.51% |
| Mar 31, 2022 | 152.39% |
| Dec 31, 2021 | 9.05% |
| Sep 30, 2021 | 36.91% |
| Jun 30, 2021 | 26.72% |